Cardiovascular Benefits of Once-a-Week GLP-1 RA Option for T2DM

Introduction

The discussion will covers several aspects of GLP-1 RA therapy including comparison to other first injectable therapies for T2DM, safety and efficacy of once-a-week GLP-1 RA.

Goals and Objectives

Understand increased cardiovascular Risks with Type 2 Diabetes patients.

Understand different cardiovascular trials design and patient population distribution.

Understand the difference between primary and secondary CV protection.

Understand the results of recent CV trials for Once-weekly dulaglutide and its implications on T2D patients.

This Course For :

Resident / Fellow
Physician

Sponsored by :

Price

Course Fee

FREE

FREE
VAT Included
See Registration Policies, Cancellations & Refunds

Contact Information

Organization : Virtual Medical Academy
Phone : 920008161
Email : info@medicalacademy.org

  • 30 Jun 2020    To    30 Jun 2020
  • 09:30 PM  To  11:30 PM
  • Certificate Available
  • SCFHS 2 CME hours
  • Online Click Here
  • 2880
  Add to Calendar 06/30/2020 09:30 PM 06/30/2020 11:30 PM Asia/ Riyadh Cardiovascular Benefits of Once-a-Week GLP-1 RA Option for T2DM Cardiovascular Benefits of Once-a-Week GLP-1 RA Option for T2DM https://medicalacademy.org/portal/event/view/1168